Literature DB >> 28269755

MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.

Qiuyue Yuan1,1, Tingge Sun1,1, Feng Ye1, Weisheng Kong2, Haofan Jin1.   

Abstract

OBJECTIVE: The aim of this study was to establish the relationship between miR-124-3p and Aurora A kinase (AURKA) in bladder cancer (BC).
METHODS: The expressions of miR-124-3p and AURKA in BC tissues and cell lines were detected using RT-PCR and western blot. BC cells were transfected with miR-124-3p mimics and AURKA siRNA. After this cell proliferation, migration, cell cycle and apoptosis were measured using CCK-8, colony formation assay, wound healing assay and cytometry tests. The relationship between miR-124-3p and AURKA was confirmed with luciferase reporter assay. Mice xenograft models were constructed to examine the effects of AURKA on BC in vivo.
RESULTS: MiR-124-3p expression was significantly down-regulated in BC tissues and cell lines, while AURKA was significantly up-regulated compared to normal samples. MiR-124-3p targeted AURKA and decreased its expression. Transfection of miR-124-3p mimics and AURKA siRNA was shown to down-regulate BC cell proliferation and migration as well as induce cell apoptosis. As suggested by xenograft models, the inhibition of AURKA can effectively suppress tumor growth.
CONCLUSION: MiR-124-3p has significant impact on proliferation, migration and apoptosis of BC cells by targeting AURKA.

Entities:  

Keywords:  AURKA; MicroRNA-124-3p; bladder cancer

Mesh:

Substances:

Year:  2017        PMID: 28269755     DOI: 10.3233/CBM-160427

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  14 in total

1.  Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis.

Authors:  Yong Liu; Yaqing Chen; Lili Tan; Hongmei Zhao; Nuan Xiao
Journal:  Heart Vessels       Date:  2019-02-08       Impact factor: 2.037

Review 2.  Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Diagn Progn       Date:  2021-07-03

3.  A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.

Authors:  Rongkang Li; Xuan Chen; Xinji Li; Guocheng Huang; Chong Lu; Zhenyu Wen; Zebo Chen; Yongqing Lai
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.

Authors:  Qiaoyun Gong; Jia'nan Xie; Yang Liu; Ying Li; Guanfang Su
Journal:  J Diabetes Res       Date:  2017-06-15       Impact factor: 4.011

5.  Spatiotemporal microRNA profile in peripheral nerve regeneration: miR-138 targets vimentin and inhibits Schwann cell migration and proliferation.

Authors:  Travis B Sullivan; Litchfield C Robert; Patrick A Teebagy; Shannon E Morgan; Evan W Beatty; Bryan J Cicuto; Peter K Nowd; Kimberly M Rieger-Christ; David J Bryan
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

6.  Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer.

Authors:  Mengjie Guo; Sicheng Lu; Hongming Huang; Yaohui Wang; Mary Q Yang; Ye Yang; Zhimin Fan; Bin Jiang; Youping Deng
Journal:  BMC Syst Biol       Date:  2018-12-14

7.  High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3.

Authors:  Meiying Li; Guangsheng Wan; Hongjie Yu; Wei Xiong
Journal:  FEBS Open Bio       Date:  2019-05-04       Impact factor: 2.693

8.  miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.

Authors:  Rong-Jun Cui; Jia-Lin Fan; Yu-Cui Lin; Yu-Jia Pan; Chi Liu; Jia-Hui Wan; Wei Wang; Zheng-Yuan Jiang; Xiu-Lan Zheng; Jie-Bing Tang; Xiao-Guang Yu
Journal:  Cancer Med       Date:  2019-08-29       Impact factor: 4.452

9.  Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.

Authors:  Chuan Zhang; Mandy Berndt-Paetz; Jochen Neuhaus
Journal:  Diagnostics (Basel)       Date:  2020-01-24

Review 10.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Authors:  Deniz Mortazavi; Behnoush Sohrabi; Meysam Mosallaei; Ziba Nariman-Saleh-Fam; Milad Bastami; Yaser Mansoori; Abdolreza Daraei; Sepideh Zununi Vahed; Shadan Navid; Zahra Saadatian; Tannaz Jamialahmadi; Yong Teng; Amirhossein Sahebkar
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.